Table 2.
Alpelisib-related rash in patients receiving prophylactic antihistamines
| No prophylaxis |
Prophylaxis | Odds Ratio |
p-value | |
|---|---|---|---|---|
| No rash | 31 | 30 | ||
| Grade 1/2 rash | 16 | 6 | 0.39 | 0.09 |
| Grade 3 rash | 12 | 7 | 0.60 | 0.43 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.